About this trial
This study will be a longitudinal multiple-visit observational study, done to identify possible bioindicators of recovery and repair of motor corticospinal pathways which may be targeted by future interventions in infants with perinatal stroke.
65 participants will be recruited and complete 1 visit at time point 1 (0-2 months), and 2 visits at each timepoints 2-5 with windows of +- 4 weeks (3-6 months, 12 months, 18 months and 24 months). Visits will consist of Magnetic Resonance Imaging (MRI) assessment during the child's natural sleep, Transcranial Magnetic Stimulation (TMS), and Motor Behavioral Assessments.
Eligibility criteria
Qualifiers
Infants with corrected gestational age between term age and 24 months of age at study enrollment
Radiologically-confirmed acute unilateral or bilateral brain lesions, including perinatal stroke, neonatal hemorrhagic or thrombotic stroke, involving the motor cortex and/or subcortical structures, and intracranial hemorrhage, involving the motor cortex and/or subcortical white matter, periventricular leukomalacia, and hypoxic-ischemic encephalopathy (HIE)
English-speaking parent/legal guardian (able to provide consent)
Disqualifiers
Other neurologic disorders unrelated to perinatal stroke/brain bleed/HIE
Metabolic disorders
Disorders of Cellular Migration and Proliferation
Acquired Traumatic Brain Injury
Trial design
Treatments tested in this trial
- Magnetic Resonance Imaging
- Behavioral Assessments
- Non invasive Transcranial Magnetic Stimulation
Treatment groups
Sponsors and collaborators
University of Wisconsin, Madison
Lead sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator